{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:14:45Z","timestamp":1759882485676,"version":"build-2065373602"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Zoster-induced Guillain\u2013Barr\u00e9 syndrome (ZGBS) is a rare neurological complication of varicella-zoster virus (VZV) reactivation. Diagnosing ZGBS is challenging due to its overlapping clinical features with other forms of Guillain\u2013Barr\u00e9 syndrome (GBS) and zoster myelitis. This report emphasizes the importance of early recognition and tailored treatment, particularly in resource-limited settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>A 45-year-old Indian male presented with a 10-day history of progressive lower limb weakness and paraesthesias. Physical examination revealed a maculovesicular rash in the left C8\u2013T2 dermatomes, areflexia, and Grade 3 muscle strength in the lower limbs and distal upper limbs, indicating lower motor neuron involvement. Cerebrospinal fluid (CSF) analysis showed albuminocytologic dissociation, and nerve conduction studies confirmed motor axonal neuropathy, consistent with the AMAN subtype of GBS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>The patient was initially treated with intravenous acyclovir for suspected herpes zoster myelitis but showed no improvement. Due to limited access to intravenous immunoglobulin (IVIG), pulse prednisone therapy was initiated. The patient required supplemental oxygen for mild respiratory distress during treatment. Prolonged prednisone therapy (11\u00a0days) resulted in significant clinical improvement, with full limb function restored within 7\u00a0days of therapy tapering and complete recovery achieved by day 18 post-treatment initiation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case underscores the diagnostic complexity of ZGBS and highlights prolonged pulse prednisone therapy as a viable alternative to IVIG in resource-constrained settings. Early diagnosis and tailored management are critical for optimizing recovery in rare conditions like ZGBS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000003583","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T17:03:09Z","timestamp":1755018189000},"page":"6107-6115","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A case report of zoster-induced Guillain\u2013Barr\u00e9 syndrome: diagnostic challenges and potential role of pulse prednisone"],"prefix":"10.1097","volume":"87","author":[{"given":"Devrakshita","family":"Mishra","sequence":"first","affiliation":[{"name":"School of Medicine, Xiamen University, Xiamen, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Nayeem","sequence":"additional","affiliation":[{"name":"School of Medicine, Xiamen University, Xiamen, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer Kumar","family":"Majety","sequence":"additional","affiliation":[{"name":"School of Medicine, Xiamen University, Xiamen, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niyaz","family":"Shaik","sequence":"additional","affiliation":[{"name":"School of Medicine, Xiamen University, Xiamen, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopichand","family":"Muppana","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Pirogov Memorial Medical University, Vinnytsia, Ukraine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.ccm.0000626836.47906.83","article-title":"774: herpes zoster complicated by severe Guillain-Barr\u00e9 syndrome","volume":"48","author":"Lee","year":"2020","journal-title":"Crit Care Med"},{"key":"R3-20251007","doi-asserted-by":"crossref","first-page":"599\u2013612","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"542\u201346","DOI":"10.4103\/aian.AIAN_721_20","article-title":"Comparison of five different electrophysiological criteria for childhood Guillain Barre syndrome","volume":"24","author":"Kasinathan","year":"2021","journal-title":"Ann Indian Acad Neurol"},{"key":"R5-20251007","first-page":"100079","article-title":"Revised Surgical CAse REport (SCARE) guideline: an update for the age of artificial intelligence","volume":"10","author":"Kerwan","year":"2025","journal-title":"Premier J Sci"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"33\u201343","DOI":"10.1093\/brain\/awt285","article-title":"Diagnosis of Guillain-Barr\u00e9 syndrome and validation of Brighton criteria","volume":"137","author":"Fokke","year":"2014","journal-title":"Brain"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12883-024-03607-1","article-title":"Guillain-Barr\u00e9 syndrome of acute motor axonal neuropathy (AMAN) type associated with herpes zoster: a case report","volume":"24","author":"Wanninayake","year":"2024","journal-title":"BMC Neurol"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"717\u201327","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"R9-20251007","doi-asserted-by":"crossref","first-page":"e16365","DOI":"10.1111\/ene.16365","article-title":"Guillain-Barr\u00e9 syndrome: a comprehensive review","volume":"31","author":"Bellanti","year":"2024","journal-title":"Eur J Neurol"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"102\u201311","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"100\u201323","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/biom14070739","article-title":"Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine","volume":"14","author":"Ishihara","year":"2024","journal-title":"Biomolecules"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"420\u201326","DOI":"10.1016\/j.neurol.2019.07.004","article-title":"The role of infections in autoimmune encephalitides","volume":"175","author":"Joubert","year":"2019","journal-title":"Rev Neurol (Paris)"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"e944505","DOI":"10.12659\/AJCR.944505","article-title":"Dangers of herpesvirus infection in SLE patients under anifrolumab treatment: case reports and clinical implications","volume":"25","author":"Larsen","year":"2024","journal-title":"Am J Case Rep"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"525\u201330","DOI":"10.1086\/655136","article-title":"Increased risk of Guillain-Barr\u00e9 syndrome following recent herpes zoster: a population-based study across Taiwan","volume":"51","author":"Kang","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"511\u201318","DOI":"10.1007\/s10096-018-3199-5","article-title":"Guillain-Barr\u00e9 syndrome following varicella-zoster virus infection","volume":"37","author":"Islam","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R17-20251007","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/v10110609","article-title":"Clinical features of varicella-zoster virus infection","volume":"10","author":"Kennedy","year":"2018","journal-title":"Viruses"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"39\u201348","DOI":"10.2214\/AJR.15.15314","article-title":"Imaging of herpesvirus infections of the CNS","volume":"206","author":"Soares","year":"2016","journal-title":"Am J Roentgenol"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12883-018-1130-4","article-title":"A retrospective case series of segmental zoster paresis of limbs: clinical, electrophysiological, and imaging characteristics","volume":"18","author":"Liu","year":"2018","journal-title":"BMC Neurol"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"13\u201319","DOI":"10.14253\/acn.2020.22.1.13","article-title":"Electrodiagnostic findings of Guillain-Barr\u00e9 syndrome","volume":"22","author":"Yoon","year":"2020","journal-title":"Ann Clin Neurophysiol"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"289","DOI":"10.21037\/atm-20-2285","article-title":"Detection of anti-ganglioside antibodies in Guillain-Barr\u00e9 syndrome","volume":"11","author":"Zhu","year":"2023","journal-title":"Ann Transl Med"},{"key":"R22-20251007","doi-asserted-by":"crossref","first-page":"491\u2013510","DOI":"10.1016\/j.ncl.2013.01.005","article-title":"Guillain-Barr\u00e9 syndrome and variants","volume":"31","author":"Dimachkie","year":"2013","journal-title":"Neurol Clin"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"1194\u201398","DOI":"10.1001\/archneur.62.8.1194","article-title":"Supportive care for patients with Guillain-Barr\u00e9 syndrome","volume":"62","author":"Hughes","year":"2005","journal-title":"Arch Neurol"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"736\u201340","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the quality standards subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12883-022-02567-8","article-title":"Comparison of the effects of different doses of Glucocorticoids on distinct subtypes of Guillain-Barr\u00e9 syndrome in Southern China","volume":"22","author":"Ma","year":"2022","journal-title":"BMC Neurol"},{"key":"R27-20251007","first-page":"CD001446","article-title":"Corticosteroids for Guillain-Barr\u00e9 syndrome","volume":"10","author":"Hughes","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R28-20251007","first-page":"9\u201311","article-title":"Corticosteroids in autoimmune diseases","volume":"22","author":"Hall","year":"1999","journal-title":"Aust Prescr"},{"key":"R29-20251007","first-page":"1\u201317","article-title":"Neurotrophic factors: an overview","volume":"1727","author":"Skaper","year":"2018","journal-title":"Methods Mol Biol"},{"key":"R30-20251007","first-page":"CD008630","article-title":"Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain Barr\u00e9 syndrome","volume":"3","author":"Hughes","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R31-20251007","first-page":"605\u201312","article-title":"A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value","volume":"51","author":"Winer","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"252\u201357","DOI":"10.1016\/j.cupe.2004.02.001","article-title":"The management of Guillain-Barr\u00e9 syndrome","volume":"14","author":"Peake","year":"2004","journal-title":"Curr Paediatr"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"719\u201322","DOI":"10.1136\/jnnp.2004.051136","article-title":"Recovery patterns and long-term prognosis for axonal Guillain-Barr\u00e9 syndrome","volume":"76","author":"Hiraga","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R34-20251007","first-page":"77\u201380","article-title":"Severe Guillain-Barr\u00e9 syndrome following primary varicella-zoster virus infection: a case report and literature review","volume":"49","author":"Chang","year":"2010","journal-title":"J Clin Virol"},{"key":"R35-20251007","first-page":"107988","article-title":"Guillain-Barr\u00e9 syndrome after varicella-zoster virus infection: a systematic review of cases and treatment outcomes","volume":"229","author":"Xu","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"R36-20251007","first-page":"120170","article-title":"Increased risk of Guillain-Barr\u00e9 syndrome following herpes zoster: a nationwide cohort study","volume":"435","author":"Luo","year":"2022","journal-title":"J Neurol Sci"},{"key":"R37-20251007","doi-asserted-by":"crossref","first-page":"100196","DOI":"10.1016\/j.nerep.2023.100196","article-title":"Chronic inflammatory demyelinating polyneuropathy or subacute Guillain-Barr\u00e9 syndrome? Not always an easy differential diagnosis","volume":"5","author":"Cecconi","year":"2024","journal-title":"Neuroimmunol Rep"},{"key":"R38-20251007","first-page":"25\u201332","article-title":"Early differential diagnosis between acute inflammatory demyelinating polyneuropathy and acute-onset chronic inflammatory demyelinating polyneuropathy in children","volume":"53","author":"Zhiwei","year":"2024","journal-title":"Clinical Factors and Routine Biomarkers, Eur J Paediatr Neurol"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"154\u201358","DOI":"10.1111\/jns.12266","article-title":"Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients","volume":"23","author":"Alessandro","year":"2018","journal-title":"J Peripher Nerv Syst"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003583","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:01:27Z","timestamp":1759827687000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003583","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"assertion":[{"value":"2025-01-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}